Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer

1. Beer, T.M.
2. Kwon, E.D.
3. Drake, C.G.
4. Fizazi, K.
5. Logothetis, C.
6. Gravis, G.
7. Ganju, V.
8. Polikoff, J.
9. Saad, F.
10. Humanski, P.
11. Piulats, J.M.
12. Mella, P.G.
13. Ng, S.S.
14. Jaeger, D.
15. Parnis, F.X.
16. Franke, F.A.
17. Puente, J.
18. Carvajal, R.
19. Sengeløv, L.
20. McHenry, M.B.
21. Varma, A.
22. Van Den Eertwegh, A.J.
23. Gerritsen, W.